Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...
An astronomer born 100 years ago is coming into his own. This week, we celebrated the 100th birthday of Wilhelm Gliese — pronounced “Gleesa” — an obscure German astronomer. Over the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback